Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2011-03-29

AUTHORS

R A Smith, J Tang, C Tudur-Smith, J P Neoptolemos, P Ghaneh

ABSTRACT

Background:The potential prognostic value of several commonly investigated immunohistochemical markers in resected pancreatic cancer is variably reported. The objective of this study was to conduct a systematic review of literature evaluating p53, p16, smad4, bcl-2, bax, vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) expression as prognostic factors in resected pancreatic adenocarcinoma and to conduct a subsequent meta-analysis to quantify the overall prognostic effect.Methods:Relevant literature was identified using Medline, EMBASE and ISI Web of Science. The primary end point was overall survival assessed on univariate analysis. Only studies analysing resected pancreatic adenocarcinoma were eligible for inclusion and the summary loge hazard ratio (logHR) and variance were pooled using an inverse variance approach. Evidence of heterogeneity was evaluated using the χ2 test for heterogeneity and its impact on the meta-analysis was assessed by the I2 statisic. Hazard ratios greater than one reflect adverse survival associated with positive immunostaining.Results:Vascular endothelial growth factor emerged as the most potentially informative prognostic marker (11 eligible studies, n=767, HR=1.51 (95% confidence interval, CI=1.18–1.92)) with no evidence of any significant publication bias (Egger's test, P=0.269). Bcl-2 (5 eligible studies, n=314, HR=0.51 (95% CI=0.38–0.68)), bax (5 studies, n=274, HR=0.63 (95% CI=0.48–0.83)) and p16 (3 studies, n=229, HR=0.63 (95% CI=0.43–0.92)) also returned significant overall survival differences, but in smaller patient series due to a lack of evaluable literature. Neither p53 (17 studies, n=925, HR=1.22 (95% CI=0.96–1.56)), smad4 (5 studies, n=540, HR=0.88 (95% CI=0.61–1.27)) nor EGFR (4 studies, n=250, HR=1.35 (95% CI=0.80–2.27)) was found to represent significant prognostic factors when analysing the pooled patient data. There was evidence of significant heterogeneity in four of the seven study groups.Conclusion:These results support the case for immunohistochemical expression of VEGF representing a significant and reproducible marker of adverse prognosis in resected pancreatic cancer. More... »

PAGES

1440-1451

References to SciGraph publications

  • 2003-01-07. Apoptosis: Targets in Pancreatic Cancer in MOLECULAR CANCER
  • 2006-06-13. Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature in BRITISH JOURNAL OF CANCER
  • 2002-03-12. Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma in BRITISH JOURNAL OF CANCER
  • 1995-06. Expression of p53 protein in pancreatic adenocarcinoma in JOURNAL OF GASTROINTESTINAL CANCER
  • 1997-07. Prognostic significance of Ki-67 antigen and p53 protein expression in pancreatic duct carcinoma: a study of the monoclonal antibodies MIB-1 and DO-7 in formalin-fixed paraffin-embedded tumour material in BRITISH JOURNAL OF CANCER
  • 1999-02-26. Prognostic significance of angiogenesis in human pancreatic cancer in BRITISH JOURNAL OF CANCER
  • 2007-09-04. Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells in CANCER AND METASTASIS REVIEWS
  • 2000-08. Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection in JOURNAL OF GASTROINTESTINAL CANCER
  • 2003-07-01. Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis in BRITISH JOURNAL OF CANCER
  • 2000-10. Tumor angiogenesis as a prognostic predictor in pancreatic cancer in JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
  • 1998-04. Prognostic significance of molecular alterations in human pancreatic carcinoma – an immunohistological study in LANGENBECK'S ARCHIVES OF SURGERY
  • 2008-07-24. Apoptotic pathways in pancreatic ductal adenocarcinoma in MOLECULAR CANCER
  • 2008-05-29. Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer in BMC CANCER
  • 2007-06-07. Practical methods for incorporating summary time-to-event data into meta-analysis in TRIALS
  • 2002-05. Clinical implication of anti-p53 antibodies and p53-protein in pancreatic disease in JOURNAL OF GASTROINTESTINAL CANCER
  • 2006-09-14. Molecular and functional diversity of vascular endothelial growth factors in MOLECULAR DIVERSITY
  • 1998-11. Molecular alterations associated with improved survival in pancreatic cancer patients treated with radiation or chemotherapy in JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
  • 2003-07. Abnormalities of tumor suppressor gene p16in pancreatic carcinoma: immunohistochemical and genetic findings compared with clinicopathological parameters in JOURNAL OF GASTROENTEROLOGY
  • 2000-08-01. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer in THE AMERICAN JOURNAL OF GASTROENTEROLOGY
  • 2006-03-31. Potential crosstalk between insulin-like growth factor receptor type 1 and epidermal growth factor receptor in progression and metastasis of pancreatic cancer in MODERN PATHOLOGY
  • 1997-04. Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma in JOURNAL OF GASTROINTESTINAL CANCER
  • 1999-05-07. Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma in BRITISH JOURNAL OF CANCER
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/bjc.2011.110

    DOI

    http://dx.doi.org/10.1038/bjc.2011.110

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1008788162

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/21448172


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Public Health and Health Services", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adenocarcinoma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Biomarkers, Tumor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cyclin-Dependent Kinase Inhibitor p16", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "ErbB Receptors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunohistochemistry", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasm Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pancreatic Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Predictive Value of Tests", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Prognosis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Proto-Oncogene Proteins c-bcl-2", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Smad4 Protein", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tumor Suppressor Protein p53", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Vascular Endothelial Growth Factor A", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "bcl-2-Associated X Protein", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, Royal Liverpool University Hospital, 5th Floor Duncan Building, Daulby Street, Liverpool L69 3GA, UK", 
              "id": "http://www.grid.ac/institutes/grid.415970.e", 
              "name": [
                "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, Royal Liverpool University Hospital, 5th Floor Duncan Building, Daulby Street, Liverpool L69 3GA, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Smith", 
            "givenName": "R A", 
            "id": "sg:person.014067200621.05", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014067200621.05"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, Royal Liverpool University Hospital, 5th Floor Duncan Building, Daulby Street, Liverpool L69 3GA, UK", 
              "id": "http://www.grid.ac/institutes/grid.415970.e", 
              "name": [
                "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, Royal Liverpool University Hospital, 5th Floor Duncan Building, Daulby Street, Liverpool L69 3GA, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tang", 
            "givenName": "J", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Current address: North West Hub for Trial Methodology Research, Centre for Medical Statistics and Health Evaluation, University of Liverpool, Liverpool, UK", 
              "id": "http://www.grid.ac/institutes/grid.10025.36", 
              "name": [
                "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, Royal Liverpool University Hospital, 5th Floor Duncan Building, Daulby Street, Liverpool L69 3GA, UK", 
                "Current address: North West Hub for Trial Methodology Research, Centre for Medical Statistics and Health Evaluation, University of Liverpool, Liverpool, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tudur-Smith", 
            "givenName": "C", 
            "id": "sg:person.01261374732.97", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261374732.97"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, Royal Liverpool University Hospital, 5th Floor Duncan Building, Daulby Street, Liverpool L69 3GA, UK", 
              "id": "http://www.grid.ac/institutes/grid.415970.e", 
              "name": [
                "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, Royal Liverpool University Hospital, 5th Floor Duncan Building, Daulby Street, Liverpool L69 3GA, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Neoptolemos", 
            "givenName": "J P", 
            "id": "sg:person.0750565077.18", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750565077.18"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, Royal Liverpool University Hospital, 5th Floor Duncan Building, Daulby Street, Liverpool L69 3GA, UK", 
              "id": "http://www.grid.ac/institutes/grid.415970.e", 
              "name": [
                "Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, Royal Liverpool University Hospital, 5th Floor Duncan Building, Daulby Street, Liverpool L69 3GA, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ghaneh", 
            "givenName": "P", 
            "id": "sg:person.07372440237.86", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07372440237.86"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s005340050045", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035600603", 
              "https://doi.org/10.1007/s005340050045"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf02822384", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1083112480", 
              "https://doi.org/10.1007/bf02822384"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s005340070020", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009097716", 
              "https://doi.org/10.1007/s005340070020"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6601095", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020644428", 
              "https://doi.org/10.1038/sj.bjc.6601095"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1385/ijgc:31:1-3:129", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031673644", 
              "https://doi.org/10.1385/ijgc:31:1-3:129"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6690248", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003090106", 
              "https://doi.org/10.1038/sj.bjc.6690248"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1745-6215-8-16", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052599734", 
              "https://doi.org/10.1186/1745-6215-8-16"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1476-4598-2-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025922030", 
              "https://doi.org/10.1186/1476-4598-2-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf02785820", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1082446687", 
              "https://doi.org/10.1007/bf02785820"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/pl00008076", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028853491", 
              "https://doi.org/10.1007/pl00008076"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1471-2407-8-153", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037036730", 
              "https://doi.org/10.1186/1471-2407-8-153"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1385/ijgc:28:1:31", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023830155", 
              "https://doi.org/10.1385/ijgc:28:1:31"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6690466", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001641229", 
              "https://doi.org/10.1038/sj.bjc.6690466"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1111/j.1572-0241.2000.02081.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011373200", 
              "https://doi.org/10.1111/j.1572-0241.2000.02081.x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bjc.1997.336", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1044188275", 
              "https://doi.org/10.1038/bjc.1997.336"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6603176", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034995899", 
              "https://doi.org/10.1038/sj.bjc.6603176"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6600133", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036385835", 
              "https://doi.org/10.1038/sj.bjc.6600133"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10555-007-9070-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034151740", 
              "https://doi.org/10.1007/s10555-007-9070-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00535-003-1119-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035416927", 
              "https://doi.org/10.1007/s00535-003-1119-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/modpathol.3800582", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039504310", 
              "https://doi.org/10.1038/modpathol.3800582"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11030-006-9027-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012921595", 
              "https://doi.org/10.1007/s11030-006-9027-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1476-4598-7-64", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050053252", 
              "https://doi.org/10.1186/1476-4598-7-64"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2011-03-29", 
        "datePublishedReg": "2011-03-29", 
        "description": "Background:The potential prognostic value of several commonly investigated immunohistochemical markers in resected pancreatic cancer is variably reported. The objective of this study was to conduct a systematic review of literature evaluating p53, p16, smad4, bcl-2, bax, vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) expression as prognostic factors in resected pancreatic adenocarcinoma and to conduct a subsequent meta-analysis to quantify the overall prognostic effect.Methods:Relevant literature was identified using Medline, EMBASE and ISI Web of Science. The primary end point was overall survival assessed on univariate analysis. Only studies analysing resected pancreatic adenocarcinoma were eligible for inclusion and the summary loge hazard ratio (logHR) and variance were pooled using an inverse variance approach. Evidence of heterogeneity was evaluated using the \u03c72 test for heterogeneity and its impact on the meta-analysis was assessed by the I2 statisic. Hazard ratios greater than one reflect adverse survival associated with positive immunostaining.Results:Vascular endothelial growth factor emerged as the most potentially informative prognostic marker (11 eligible studies, n=767, HR=1.51 (95% confidence interval, CI=1.18\u20131.92)) with no evidence of any significant publication bias (Egger's test, P=0.269). Bcl-2 (5 eligible studies, n=314, HR=0.51 (95% CI=0.38\u20130.68)), bax (5 studies, n=274, HR=0.63 (95% CI=0.48\u20130.83)) and p16 (3 studies, n=229, HR=0.63 (95% CI=0.43\u20130.92)) also returned significant overall survival differences, but in smaller patient series due to a lack of evaluable literature. Neither p53 (17 studies, n=925, HR=1.22 (95% CI=0.96\u20131.56)), smad4 (5 studies, n=540, HR=0.88 (95% CI=0.61\u20131.27)) nor EGFR (4 studies, n=250, HR=1.35 (95% CI=0.80\u20132.27)) was found to represent significant prognostic factors when analysing the pooled patient data. There was evidence of significant heterogeneity in four of the seven study groups.Conclusion:These results support the case for immunohistochemical expression of VEGF representing a significant and reproducible marker of adverse prognosis in resected pancreatic cancer.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/bjc.2011.110", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1017082", 
            "issn": [
              "0007-0920", 
              "1532-1827"
            ], 
            "name": "British Journal of Cancer", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "9", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "104"
          }
        ], 
        "keywords": [
          "vascular endothelial growth factor", 
          "endothelial growth factor", 
          "pancreatic cancer", 
          "prognostic factors", 
          "pancreatic adenocarcinoma", 
          "prognostic marker", 
          "significant overall survival difference", 
          "epidermal growth factor receptor expression", 
          "growth factor", 
          "informative prognostic markers", 
          "growth factor receptor expression", 
          "primary end point", 
          "significant prognostic factors", 
          "overall survival difference", 
          "small patient series", 
          "potential prognostic value", 
          "Bcl-2", 
          "immunohistochemical prognostic markers", 
          "inverse variance approach", 
          "pooled patient data", 
          "factor receptor expression", 
          "significant publication bias", 
          "overall prognostic effect", 
          "evidence of heterogeneity", 
          "overall survival", 
          "hazard ratio", 
          "adverse survival", 
          "prognostic effect", 
          "patient series", 
          "adverse prognosis", 
          "prognostic value", 
          "survival differences", 
          "univariate analysis", 
          "receptor expression", 
          "immunohistochemical expression", 
          "immunohistochemical markers", 
          "study group", 
          "positive immunostaining", 
          "systematic review", 
          "publication bias", 
          "end point", 
          "patient data", 
          "\u03c72 test", 
          "ISI Web", 
          "cancer", 
          "significant heterogeneity", 
          "reproducible marker", 
          "adenocarcinoma", 
          "markers", 
          "p16", 
          "survival", 
          "SMAD4", 
          "p53", 
          "Bax", 
          "relevant literature", 
          "EMBASE", 
          "evidence", 
          "prognosis", 
          "factors", 
          "MEDLINE", 
          "expression", 
          "EGFR", 
          "immunostaining", 
          "study", 
          "heterogeneity", 
          "review", 
          "group", 
          "literature", 
          "differences", 
          "cases", 
          "lack", 
          "test", 
          "effect", 
          "objective", 
          "hazards", 
          "data", 
          "inclusion", 
          "ratio", 
          "bias", 
          "impact", 
          "analysis", 
          "Web", 
          "series", 
          "variance", 
          "results", 
          "values", 
          "point", 
          "variance approach", 
          "approach", 
          "science"
        ], 
        "name": "Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer", 
        "pagination": "1440-1451", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1008788162"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/bjc.2011.110"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "21448172"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/bjc.2011.110", 
          "https://app.dimensions.ai/details/publication/pub.1008788162"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-09-02T15:55", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_539.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/bjc.2011.110"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.2011.110'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.2011.110'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.2011.110'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.2011.110'


     

    This table displays all metadata directly associated to this object as RDF triples.

    330 TRIPLES      21 PREDICATES      152 URIs      122 LITERALS      22 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/bjc.2011.110 schema:about N2d4002b0668443ab8c4e4176669d7b1b
    2 N34d0f3e60ccf48d08ca9f9cade1c8a7a
    3 N3bc781ea064b42daa869c7fcc8845e62
    4 N3ec8b56e873c440da62270c25ee5ad70
    5 N440d05ad9728416a846ad6269d896d50
    6 N5438c0ae2ed7466eabb9c91ba6552eaa
    7 N5c61954af30b47aba27380e81511e9cd
    8 N5d447fea53744d448133153305626a9c
    9 N8450640a0ce846eeb8a98bfc36632576
    10 N8bf3707479274625b0ad1315a76d43cd
    11 N9a7335ab257a4f71bc2815c8905405c5
    12 Nba87aab4ce3a47bca0510972de199726
    13 Nbc982e6d71b94b6fb30f09616b4e5b12
    14 Ncff1f852c23540c0934b0cf4c0394ac7
    15 Ne8cb20a81cd14d818964b156baf9b22f
    16 anzsrc-for:11
    17 anzsrc-for:1117
    18 schema:author Nb6c3dd3c317e4f5fb8f1582396dee744
    19 schema:citation sg:pub.10.1007/bf02785820
    20 sg:pub.10.1007/bf02822384
    21 sg:pub.10.1007/pl00008076
    22 sg:pub.10.1007/s005340050045
    23 sg:pub.10.1007/s005340070020
    24 sg:pub.10.1007/s00535-003-1119-6
    25 sg:pub.10.1007/s10555-007-9070-2
    26 sg:pub.10.1007/s11030-006-9027-3
    27 sg:pub.10.1038/bjc.1997.336
    28 sg:pub.10.1038/modpathol.3800582
    29 sg:pub.10.1038/sj.bjc.6600133
    30 sg:pub.10.1038/sj.bjc.6601095
    31 sg:pub.10.1038/sj.bjc.6603176
    32 sg:pub.10.1038/sj.bjc.6690248
    33 sg:pub.10.1038/sj.bjc.6690466
    34 sg:pub.10.1111/j.1572-0241.2000.02081.x
    35 sg:pub.10.1186/1471-2407-8-153
    36 sg:pub.10.1186/1476-4598-2-6
    37 sg:pub.10.1186/1476-4598-7-64
    38 sg:pub.10.1186/1745-6215-8-16
    39 sg:pub.10.1385/ijgc:28:1:31
    40 sg:pub.10.1385/ijgc:31:1-3:129
    41 schema:datePublished 2011-03-29
    42 schema:datePublishedReg 2011-03-29
    43 schema:description Background:The potential prognostic value of several commonly investigated immunohistochemical markers in resected pancreatic cancer is variably reported. The objective of this study was to conduct a systematic review of literature evaluating p53, p16, smad4, bcl-2, bax, vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) expression as prognostic factors in resected pancreatic adenocarcinoma and to conduct a subsequent meta-analysis to quantify the overall prognostic effect.Methods:Relevant literature was identified using Medline, EMBASE and ISI Web of Science. The primary end point was overall survival assessed on univariate analysis. Only studies analysing resected pancreatic adenocarcinoma were eligible for inclusion and the summary loge hazard ratio (logHR) and variance were pooled using an inverse variance approach. Evidence of heterogeneity was evaluated using the χ2 test for heterogeneity and its impact on the meta-analysis was assessed by the I2 statisic. Hazard ratios greater than one reflect adverse survival associated with positive immunostaining.Results:Vascular endothelial growth factor emerged as the most potentially informative prognostic marker (11 eligible studies, n=767, HR=1.51 (95% confidence interval, CI=1.18–1.92)) with no evidence of any significant publication bias (Egger's test, P=0.269). Bcl-2 (5 eligible studies, n=314, HR=0.51 (95% CI=0.38–0.68)), bax (5 studies, n=274, HR=0.63 (95% CI=0.48–0.83)) and p16 (3 studies, n=229, HR=0.63 (95% CI=0.43–0.92)) also returned significant overall survival differences, but in smaller patient series due to a lack of evaluable literature. Neither p53 (17 studies, n=925, HR=1.22 (95% CI=0.96–1.56)), smad4 (5 studies, n=540, HR=0.88 (95% CI=0.61–1.27)) nor EGFR (4 studies, n=250, HR=1.35 (95% CI=0.80–2.27)) was found to represent significant prognostic factors when analysing the pooled patient data. There was evidence of significant heterogeneity in four of the seven study groups.Conclusion:These results support the case for immunohistochemical expression of VEGF representing a significant and reproducible marker of adverse prognosis in resected pancreatic cancer.
    44 schema:genre article
    45 schema:isAccessibleForFree true
    46 schema:isPartOf N4dbfddbf44a247779f97d94df0df466e
    47 Ncb3f6ef9e0f848c8a202e508ea56e2c6
    48 sg:journal.1017082
    49 schema:keywords Bax
    50 Bcl-2
    51 EGFR
    52 EMBASE
    53 ISI Web
    54 MEDLINE
    55 SMAD4
    56 Web
    57 adenocarcinoma
    58 adverse prognosis
    59 adverse survival
    60 analysis
    61 approach
    62 bias
    63 cancer
    64 cases
    65 data
    66 differences
    67 effect
    68 end point
    69 endothelial growth factor
    70 epidermal growth factor receptor expression
    71 evidence
    72 evidence of heterogeneity
    73 expression
    74 factor receptor expression
    75 factors
    76 group
    77 growth factor
    78 growth factor receptor expression
    79 hazard ratio
    80 hazards
    81 heterogeneity
    82 immunohistochemical expression
    83 immunohistochemical markers
    84 immunohistochemical prognostic markers
    85 immunostaining
    86 impact
    87 inclusion
    88 informative prognostic markers
    89 inverse variance approach
    90 lack
    91 literature
    92 markers
    93 objective
    94 overall prognostic effect
    95 overall survival
    96 overall survival difference
    97 p16
    98 p53
    99 pancreatic adenocarcinoma
    100 pancreatic cancer
    101 patient data
    102 patient series
    103 point
    104 pooled patient data
    105 positive immunostaining
    106 potential prognostic value
    107 primary end point
    108 prognosis
    109 prognostic effect
    110 prognostic factors
    111 prognostic marker
    112 prognostic value
    113 publication bias
    114 ratio
    115 receptor expression
    116 relevant literature
    117 reproducible marker
    118 results
    119 review
    120 science
    121 series
    122 significant heterogeneity
    123 significant overall survival difference
    124 significant prognostic factors
    125 significant publication bias
    126 small patient series
    127 study
    128 study group
    129 survival
    130 survival differences
    131 systematic review
    132 test
    133 univariate analysis
    134 values
    135 variance
    136 variance approach
    137 vascular endothelial growth factor
    138 χ2 test
    139 schema:name Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer
    140 schema:pagination 1440-1451
    141 schema:productId N16c61d3640bf426ba9ca332636216a58
    142 N9557c36e7e9d41c497d84949ed15048e
    143 Ne14e88c71ea14118b631a11c7daf9874
    144 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008788162
    145 https://doi.org/10.1038/bjc.2011.110
    146 schema:sdDatePublished 2022-09-02T15:55
    147 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    148 schema:sdPublisher N8b23a7badc7047b59ef6b5664e75f533
    149 schema:url https://doi.org/10.1038/bjc.2011.110
    150 sgo:license sg:explorer/license/
    151 sgo:sdDataset articles
    152 rdf:type schema:ScholarlyArticle
    153 N16c61d3640bf426ba9ca332636216a58 schema:name pubmed_id
    154 schema:value 21448172
    155 rdf:type schema:PropertyValue
    156 N2d4002b0668443ab8c4e4176669d7b1b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Immunohistochemistry
    158 rdf:type schema:DefinedTerm
    159 N34d0f3e60ccf48d08ca9f9cade1c8a7a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    160 schema:name Smad4 Protein
    161 rdf:type schema:DefinedTerm
    162 N3bc781ea064b42daa869c7fcc8845e62 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Adenocarcinoma
    164 rdf:type schema:DefinedTerm
    165 N3ec8b56e873c440da62270c25ee5ad70 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    166 schema:name Proto-Oncogene Proteins c-bcl-2
    167 rdf:type schema:DefinedTerm
    168 N440d05ad9728416a846ad6269d896d50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    169 schema:name Tumor Suppressor Protein p53
    170 rdf:type schema:DefinedTerm
    171 N4dbfddbf44a247779f97d94df0df466e schema:volumeNumber 104
    172 rdf:type schema:PublicationVolume
    173 N5438c0ae2ed7466eabb9c91ba6552eaa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    174 schema:name Cyclin-Dependent Kinase Inhibitor p16
    175 rdf:type schema:DefinedTerm
    176 N5c61954af30b47aba27380e81511e9cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    177 schema:name ErbB Receptors
    178 rdf:type schema:DefinedTerm
    179 N5d447fea53744d448133153305626a9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    180 schema:name Predictive Value of Tests
    181 rdf:type schema:DefinedTerm
    182 N5d86af7a66b2415eae2d5f0e280be3c3 schema:affiliation grid-institutes:grid.415970.e
    183 schema:familyName Tang
    184 schema:givenName J
    185 rdf:type schema:Person
    186 N69a1658bbe6f4241919086b35d95ebca rdf:first sg:person.0750565077.18
    187 rdf:rest N7601d22b10674b5b9753140a56281005
    188 N736bae4eba0d4a2186be79e6d6f27017 rdf:first N5d86af7a66b2415eae2d5f0e280be3c3
    189 rdf:rest Na2e4632004b446bea2e6f8ee385eea70
    190 N7601d22b10674b5b9753140a56281005 rdf:first sg:person.07372440237.86
    191 rdf:rest rdf:nil
    192 N8450640a0ce846eeb8a98bfc36632576 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    193 schema:name Biomarkers, Tumor
    194 rdf:type schema:DefinedTerm
    195 N8b23a7badc7047b59ef6b5664e75f533 schema:name Springer Nature - SN SciGraph project
    196 rdf:type schema:Organization
    197 N8bf3707479274625b0ad1315a76d43cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    198 schema:name Pancreatic Neoplasms
    199 rdf:type schema:DefinedTerm
    200 N9557c36e7e9d41c497d84949ed15048e schema:name dimensions_id
    201 schema:value pub.1008788162
    202 rdf:type schema:PropertyValue
    203 N9a7335ab257a4f71bc2815c8905405c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    204 schema:name Vascular Endothelial Growth Factor A
    205 rdf:type schema:DefinedTerm
    206 Na2e4632004b446bea2e6f8ee385eea70 rdf:first sg:person.01261374732.97
    207 rdf:rest N69a1658bbe6f4241919086b35d95ebca
    208 Nb6c3dd3c317e4f5fb8f1582396dee744 rdf:first sg:person.014067200621.05
    209 rdf:rest N736bae4eba0d4a2186be79e6d6f27017
    210 Nba87aab4ce3a47bca0510972de199726 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    211 schema:name bcl-2-Associated X Protein
    212 rdf:type schema:DefinedTerm
    213 Nbc982e6d71b94b6fb30f09616b4e5b12 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    214 schema:name Neoplasm Proteins
    215 rdf:type schema:DefinedTerm
    216 Ncb3f6ef9e0f848c8a202e508ea56e2c6 schema:issueNumber 9
    217 rdf:type schema:PublicationIssue
    218 Ncff1f852c23540c0934b0cf4c0394ac7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    219 schema:name Humans
    220 rdf:type schema:DefinedTerm
    221 Ne14e88c71ea14118b631a11c7daf9874 schema:name doi
    222 schema:value 10.1038/bjc.2011.110
    223 rdf:type schema:PropertyValue
    224 Ne8cb20a81cd14d818964b156baf9b22f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    225 schema:name Prognosis
    226 rdf:type schema:DefinedTerm
    227 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    228 schema:name Medical and Health Sciences
    229 rdf:type schema:DefinedTerm
    230 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
    231 schema:name Public Health and Health Services
    232 rdf:type schema:DefinedTerm
    233 sg:journal.1017082 schema:issn 0007-0920
    234 1532-1827
    235 schema:name British Journal of Cancer
    236 schema:publisher Springer Nature
    237 rdf:type schema:Periodical
    238 sg:person.01261374732.97 schema:affiliation grid-institutes:grid.10025.36
    239 schema:familyName Tudur-Smith
    240 schema:givenName C
    241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261374732.97
    242 rdf:type schema:Person
    243 sg:person.014067200621.05 schema:affiliation grid-institutes:grid.415970.e
    244 schema:familyName Smith
    245 schema:givenName R A
    246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014067200621.05
    247 rdf:type schema:Person
    248 sg:person.07372440237.86 schema:affiliation grid-institutes:grid.415970.e
    249 schema:familyName Ghaneh
    250 schema:givenName P
    251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07372440237.86
    252 rdf:type schema:Person
    253 sg:person.0750565077.18 schema:affiliation grid-institutes:grid.415970.e
    254 schema:familyName Neoptolemos
    255 schema:givenName J P
    256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750565077.18
    257 rdf:type schema:Person
    258 sg:pub.10.1007/bf02785820 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082446687
    259 https://doi.org/10.1007/bf02785820
    260 rdf:type schema:CreativeWork
    261 sg:pub.10.1007/bf02822384 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083112480
    262 https://doi.org/10.1007/bf02822384
    263 rdf:type schema:CreativeWork
    264 sg:pub.10.1007/pl00008076 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028853491
    265 https://doi.org/10.1007/pl00008076
    266 rdf:type schema:CreativeWork
    267 sg:pub.10.1007/s005340050045 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035600603
    268 https://doi.org/10.1007/s005340050045
    269 rdf:type schema:CreativeWork
    270 sg:pub.10.1007/s005340070020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009097716
    271 https://doi.org/10.1007/s005340070020
    272 rdf:type schema:CreativeWork
    273 sg:pub.10.1007/s00535-003-1119-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035416927
    274 https://doi.org/10.1007/s00535-003-1119-6
    275 rdf:type schema:CreativeWork
    276 sg:pub.10.1007/s10555-007-9070-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034151740
    277 https://doi.org/10.1007/s10555-007-9070-2
    278 rdf:type schema:CreativeWork
    279 sg:pub.10.1007/s11030-006-9027-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012921595
    280 https://doi.org/10.1007/s11030-006-9027-3
    281 rdf:type schema:CreativeWork
    282 sg:pub.10.1038/bjc.1997.336 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044188275
    283 https://doi.org/10.1038/bjc.1997.336
    284 rdf:type schema:CreativeWork
    285 sg:pub.10.1038/modpathol.3800582 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039504310
    286 https://doi.org/10.1038/modpathol.3800582
    287 rdf:type schema:CreativeWork
    288 sg:pub.10.1038/sj.bjc.6600133 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036385835
    289 https://doi.org/10.1038/sj.bjc.6600133
    290 rdf:type schema:CreativeWork
    291 sg:pub.10.1038/sj.bjc.6601095 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020644428
    292 https://doi.org/10.1038/sj.bjc.6601095
    293 rdf:type schema:CreativeWork
    294 sg:pub.10.1038/sj.bjc.6603176 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034995899
    295 https://doi.org/10.1038/sj.bjc.6603176
    296 rdf:type schema:CreativeWork
    297 sg:pub.10.1038/sj.bjc.6690248 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003090106
    298 https://doi.org/10.1038/sj.bjc.6690248
    299 rdf:type schema:CreativeWork
    300 sg:pub.10.1038/sj.bjc.6690466 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001641229
    301 https://doi.org/10.1038/sj.bjc.6690466
    302 rdf:type schema:CreativeWork
    303 sg:pub.10.1111/j.1572-0241.2000.02081.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1011373200
    304 https://doi.org/10.1111/j.1572-0241.2000.02081.x
    305 rdf:type schema:CreativeWork
    306 sg:pub.10.1186/1471-2407-8-153 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037036730
    307 https://doi.org/10.1186/1471-2407-8-153
    308 rdf:type schema:CreativeWork
    309 sg:pub.10.1186/1476-4598-2-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025922030
    310 https://doi.org/10.1186/1476-4598-2-6
    311 rdf:type schema:CreativeWork
    312 sg:pub.10.1186/1476-4598-7-64 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050053252
    313 https://doi.org/10.1186/1476-4598-7-64
    314 rdf:type schema:CreativeWork
    315 sg:pub.10.1186/1745-6215-8-16 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052599734
    316 https://doi.org/10.1186/1745-6215-8-16
    317 rdf:type schema:CreativeWork
    318 sg:pub.10.1385/ijgc:28:1:31 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023830155
    319 https://doi.org/10.1385/ijgc:28:1:31
    320 rdf:type schema:CreativeWork
    321 sg:pub.10.1385/ijgc:31:1-3:129 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031673644
    322 https://doi.org/10.1385/ijgc:31:1-3:129
    323 rdf:type schema:CreativeWork
    324 grid-institutes:grid.10025.36 schema:alternateName Current address: North West Hub for Trial Methodology Research, Centre for Medical Statistics and Health Evaluation, University of Liverpool, Liverpool, UK
    325 schema:name Current address: North West Hub for Trial Methodology Research, Centre for Medical Statistics and Health Evaluation, University of Liverpool, Liverpool, UK
    326 Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, Royal Liverpool University Hospital, 5th Floor Duncan Building, Daulby Street, Liverpool L69 3GA, UK
    327 rdf:type schema:Organization
    328 grid-institutes:grid.415970.e schema:alternateName Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, Royal Liverpool University Hospital, 5th Floor Duncan Building, Daulby Street, Liverpool L69 3GA, UK
    329 schema:name Division of Surgery and Oncology, School of Cancer Studies, University of Liverpool, Royal Liverpool University Hospital, 5th Floor Duncan Building, Daulby Street, Liverpool L69 3GA, UK
    330 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...